Paratek Pharmaceuticals, Inc.

PRTKCIK 0001178711 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 27, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0105

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Paratek Pharmaceuticals, Inc.

Name	Roles	Filings
Franson Timothy R	Director	4
Stein Jeffrey	Director	4
Bigham Michael	OfficerDirector	3
Baylor-Henry Minnie	Director	3
Brenner Randall B.	Officer	3

Showing 1-5 of 13

Per pagePage 1 of 3Next

All filings

39 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Sep 21, 2023	Radie Robert S Director	DDisposition	53,000	-	-
Sep 21, 2023	Dietz Thomas John Director	DDisposition	49,250	-	-
Sep 21, 2023	Loh Evan CEO · Director	DDisposition	1,069,231	-	-
Sep 21, 2023	Woodrow Adam President & Chief Commercial	DDisposition	622,284	-	-
Sep 21, 2023	Franson Timothy R Director	DDisposition	52,000	-	-

Showing 1-5 of 39

Per pagePage 1 of 8Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value